Clinical Trial Update: Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing LXI-15028 with esomeprazole for erosive esophagitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis

Drugs mentioned

• Esomeprazole (Esomeprazole)
• LXI-15028

Snippet

Sponsor: Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. | Conditions: Erosive Esophagitis (EE) | Phase 3 | Status: COMPLETED